MeSH Browser

MeSH Supplementary: VIP regimen 2
Unique ID: C508238
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/C508238
Registry Number: 0
Heading Mapped to: *Antineoplastic Combined Chemotherapy Protocols; Ifosfamide; Vincristine; Peplomycin
Frequency: 0
Note: chemotherapy protocol consisting of vincristine, ifosfamide and peplomycin for treatment of newly diagnosed stage D2 prostate cancer
Source: Hinyokika Kiyo 2005 Dec;51(12):789-92
Date of Entry: 2006/03/01

VIP regimen 2 MeSH Supplementary Concept Data 2024